Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hannah Fernandez-Gotico"'
Publikováno v:
Journal of Neuroscience Nursing. 49:31-36
Background and purpose The approved treatment by the Food and Drug Administration for acute ischemic stroke is intravenous tissue-type plasminogen activator (IV tPA). After IV tPA administration, patients are monitored for adverse events using an Ame
Publikováno v:
Stroke. 45
RESEARCH QUESTION: When do adverse events occur within 24 hours after intravenous tissue-type plasminogen activator (IV tPA) treatment for acute stroke? BACKGROUND AND PURPOSE: The FDA approved medication for ischemic stroke is IV tPA. Patients are m
Autor:
Fernandez-Gotico H; Questions or comments about this article may be directed to Hannah Fernandez-Gotico, MS RN-BC CPHQ at hannah.fernandez-gotico@kp.org. She is a Quality Director of Clinical Services, Kaiser Permanente, South San Francisco, CA. Tiffany Lightfoot, MS RN CPPS, is Healthcare Consultant, The Rosenberger Group, Los Angeles, CA. Melissa Meighan, MS RN CNRN, is Regional Stroke Coordinator, Kaiser Northern California, Oakland, CA., Lightfoot T, Meighan M
Publikováno v:
The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses [J Neurosci Nurs] 2017 Feb; Vol. 49 (1), pp. 31-36.